Sitafloxacin
From Wikipedia, the free encyclopedia
| Sitafloxacin | |
|---|---|
| IUPAC name | 7-[(4S)-4-amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid |
| Other names | DU-6859a |
| Identifiers | |
| CAS number | [127254-12-0] |
| PubChem | |
| SMILES | C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl) N(C=C(C4=O)C(=O)O)C5CC5F)F |
| Properties | |
| Molecular formula | C19H18ClF2N3O3 |
| Molar mass | 409.814326 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
Sitafloxacin (also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Pharmaceutical Co. Ltd, who have also brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently under development in Japan.
|
|||||||||||

